KCT0009513已完成未知
Prognostic effect of ductal carcinoma in situ in breast cancer with breast cancer susceptibility gene (BRCA) 1/2 mutations
适应症
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 入组人数
- 201
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Observational Study
入排标准
- 年龄范围
- 18(Year) 至 o Limit（—）
- 性别
- All
入选标准
- •Breast cancer patients over 18 years old who had available results for BRCA mutations
排除标准
- •Patients without BRCA mutation testing
研究者
相似试验
招募中
3 期
Management of low-risk ductal carcinoma in situ (low-risk DCIS): a non-randomized, multicenter, non-inferiority trial; standard therapy versus active surveillance.low risk ductal carcinoma in situpre-stage breast cancer10006291NL-OMON54716Antoni van Leeuwenhoek Ziekenhuis2,500
进行中（未招募）
3 期
Prospective Randomized Study of Accelerated Radiation Therapy (PRART)Breast CancerNCT04175210Weill Medical College of Cornell University400
进行中（未招募）
不适用
The AUS-PREDICT Registry for DCIS Patients With DCISionRT TestingDCISNCT04916808PreludeDx1,500
已完成
不适用
Perioperative Cancer Cell Dissemination and Systemic Immune Suppression in Resectable Ductal Pancreatic AdenocarcinomaPancreatic NeoplasmsAdenocarcinomaNeoplasm Circulating CellsTumor Markers, BiologicalMonitoring, ImmunologicNCT00495924KU Leuven100
招募中
不适用
The PREDICT Registry:DCISStage 0 Breast CancerDuctal Breast Carcinoma In SituNCT03448926PreludeDx3,000